NF1 and malignant peripheral nerve sheath tumor: In the present study, we tested a new ATP-competitive “active-site” mTOR inhibitor AZD8055 that directly suppresses the mTOR catalytic activity in human NF1-associated MPNST cell lines and plexiform neurofibromas derived primary Schwann cells.